Rafael Pulido Murillo-rekin lankidetzan egindako argitalpenak (12)

2023

  1. Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease

    European Journal of Human Genetics, Vol. 31, Núm. 5, pp. 568-577

2021

  1. A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons

    Human Mutation, Vol. 42, Núm. 5, pp. 551-566

2019

  1. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function

    Cells, Vol. 8, Núm. 12

2017

  1. Insights into the pathological mechanisms of p85α mutations using a yeast-based phosphatidylinositol 3-kinase model

    Bioscience Reports, Vol. 37, Núm. 2

2015

  1. A functional dissection of PTEN N-terminus: Implications in PTEN subcellular targeting and tumor suppressor activity

    PLoS ONE, Vol. 10, Núm. 4

  2. Yeast-based methods to assess PTEN phosphoinositide phosphatase activity in vivo

    Methods, Vol. 77, pp. 172-179

2014

  1. A unified nomenclature and amino acid numbering for human PTEN

    Science Signaling, Vol. 7, Núm. 332

2011

  1. A comprehensive functional analysis of PTEN mutations: Implications in tumor- and autism-related syndromes

    Human Molecular Genetics, Vol. 20, Núm. 21, pp. 4132-4142

  2. Phylogenetic and genetic linkage between novel atypical dual-specificity phosphatases from non-metazoan organisms

    Molecular Genetics and Genomics, Vol. 285, Núm. 4, pp. 341-354

2009

  1. Phosphatidylinositol 3-kinase-dependent activation of mammalian protein kinase B/Akt in Saccharomyces cerevisiae, an in vivo model for the functional study of Akt mutations

    Journal of Biological Chemistry, Vol. 284, Núm. 20, pp. 13373-13383

2008

  1. Assessment of PTEN tumor suppressor activity in nonmammalian models: The year of the yeast

    Oncogene, Vol. 27, Núm. 41, pp. 5431-5442

2007

  1. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN

    Cancer Research, Vol. 67, Núm. 20, pp. 9731-9739